52 related articles for article (PubMed ID: 38752261)
1. Long Non-coding RNA X-Inactive Specific Transcript Promotes Esophageal Squamous Cell Carcinoma Progression via the MicroRNA 34a/Zinc Finger E-box-Binding Homeobox 1 Pathway.
Guo B; He M; Ma M; Tian Z; Jin J; Tian G
Dig Dis Sci; 2024 Apr; 69(4):1169-1181. PubMed ID: 38366093
[TBL] [Abstract][Full Text] [Related]
2. Circular RNA circMAN1A2 promotes ovarian cancer progression through the microRNA-135a-3p/IL1RAP/TAK1 pathway.
Li B; Hu C; Zhao D; Nie M; Wang X
PeerJ; 2024; 12():e16967. PubMed ID: 38680890
[TBL] [Abstract][Full Text] [Related]
3. Circ-ZEB1 promotes PIK3CA expression by silencing miR-199a-3p and affects the proliferation and apoptosis of hepatocellular carcinoma.
Liu W; Zheng L; Zhang R; Hou P; Wang J; Wu L; Li J
Mol Cancer; 2022 Mar; 21(1):72. PubMed ID: 35277182
[TBL] [Abstract][Full Text] [Related]
4. Expression of Concern: Circular RNA S-7 promotes ovarian cancer EMT via sponging miR-641 to upregulate ZEB1 and MDM2.
Biosci Rep; 2024 May; 44(5):. PubMed ID: 38682476
[No Abstract] [Full Text] [Related]
5. GLUT3 transcriptional activation by ZEB1 fuels the Warburg effect and promotes ovarian cancer progression.
Lin F; Ma L; Yu S; Lin J; Xu Z; Xia H; Song Y; Huang W; Wu Y; Chen Y; Liu X; Xia J; Huang X
Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119715. PubMed ID: 38583782
[TBL] [Abstract][Full Text] [Related]
6. The oncogenic roles of GPR176 in ovarian cancer: a molecular target for aggressiveness and gene therapy.
Yang N; Yun WJ; Cui ZG; Zheng HC
J Obstet Gynaecol; 2024 Dec; 44(1):2347430. PubMed ID: 38835234
[TBL] [Abstract][Full Text] [Related]
7. lncRNA799/TBL1XR1/ZEB1 Axis Forms a Feedback Loop to Promote the Epithelial-Mesenchymal Transition of Cervical Cancer Cells.
Liao L; Huang P; Zhao J; Wang Z; Chen H; Zhang C; Huang L
Crit Rev Eukaryot Gene Expr; 2024; 34(2):33-43. PubMed ID: 38073440
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-135a-3p as a promising biomarker and nucleic acid therapeutic agent for ovarian cancer.
Fukagawa S; Miyata K; Yotsumoto F; Kiyoshima C; Nam SO; Anan H; Katsuda T; Miyahara D; Murata M; Yagi H; Shirota K; Yasunaga S; Kato K; Miyamoto S
Cancer Sci; 2017 May; 108(5):886-896. PubMed ID: 28231414
[TBL] [Abstract][Full Text] [Related]
9. ZNF146 regulates cell cycle progression via TFDP1 and DEPDC1B in ovarian cancer cells.
Zhao R; Song N; Ning X; Chen X; Ma R
Reproduction; 2024 Jul; 168(1):. PubMed ID: 38614125
[TBL] [Abstract][Full Text] [Related]
10. An LRPPRC-HAPSTR1-PSMD14 interaction regulates tumor progression in ovarian cancer.
Li D; Wang M
Aging (Albany NY); 2024 Apr; 16(8):6773-6795. PubMed ID: 38643468
[TBL] [Abstract][Full Text] [Related]
11. Low PDE4A expression promoted the progression of ovarian cancer by inducing Snail nuclear translocation.
Wang J; Gu Q; Liu Y; Huang X; Zhang J; Liu B; Li R; Linghu H
Exp Cell Res; 2024 May; ():114100. PubMed ID: 38797258
[TBL] [Abstract][Full Text] [Related]
12. CircAGFG1 Promotes Ovarian Cancer Progression Through the miR-409-3 p/ZEB1 Axis.
Luo J; Zhong H; Guo M; Xiao P; Cao R; Zhao M; Jing Y
Technol Cancer Res Treat; 2024; 23():15330338241252423. PubMed ID: 38752261
[TBL] [Abstract][Full Text] [Related]
13. The role of microRNA-185 in the pathogenesis of human diseases: A focus on cancer.
Pordel S; Khorrami M; Saadatpour F; Rezaee D; Cho WC; Jahani S; Aghaei-Zarch SM; Hashemi E; Najafi S
Pathol Res Pract; 2023 Sep; 249():154729. PubMed ID: 37639952
[TBL] [Abstract][Full Text] [Related]
14. microRNA-382 as a tumor suppressor? Roles in tumorigenesis and clinical significance.
Fattahi M; Shahrabi S; Saadatpour F; Rezaee D; Beyglu Z; Delavari S; Amrolahi A; Ahmadi S; Bagheri-Mohammadi S; Noori E; Majidpoor J; Nouri S; Aghaei-Zarch SM; Falahi S; Najafi S; Le BN
Int J Biol Macromol; 2023 Oct; 250():125863. PubMed ID: 37467828
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-122 in human cancers: from mechanistic to clinical perspectives.
Faramin Lashkarian M; Hashemipour N; Niaraki N; Soghala S; Moradi A; Sarhangi S; Hatami M; Aghaei-Zarch F; Khosravifar M; Mohammadzadeh A; Najafi S; Majidpoor J; Farnia P; Aghaei-Zarch SM
Cancer Cell Int; 2023 Feb; 23(1):29. PubMed ID: 36803831
[TBL] [Abstract][Full Text] [Related]
16. MiR-211 plays a dual role in cancer development: From tumor suppressor to tumor enhancer.
Shirvani H; Ghanavi J; Aliabadi A; Mousavinasab F; Talebi M; Majidpoor J; Najafi S; Miryounesi SM; Aghaei Zarch SM
Cell Signal; 2023 Jan; 101():110504. PubMed ID: 36309329
[TBL] [Abstract][Full Text] [Related]
17. The emerging roles and potential applications of circular RNAs in ovarian cancer: a comprehensive review.
Najafi S
J Cancer Res Clin Oncol; 2023 May; 149(5):2211-2234. PubMed ID: 36053324
[TBL] [Abstract][Full Text] [Related]
18. CircINTS4 Facilitates Chemoresistance of TNBC by Competitively Binding miR-129-5p/POM121 Axis.
Tang Q; Zhou F; Yang C; Dai J; Li J; He Y
J Oncol; 2022; 2022():2630864. PubMed ID: 35419056
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
